Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Fidelity Select Sector funds -- Ignore unavailable to you. Want to Upgrade?

To: Julius Wong who wrote (2882)	9/4/2000 12:00:01 PM
From: seminole	Respond to of 4916

Julius Average people/small investors are looking for ways to invest in Biotech. They know biotech is a hot sector. The way most of these small investors should find their biotech fix is through biotech sector funds and this is one of the reasons I expect good returns in biotech for the rest of the year. The Barron's article may lead readers looking for biotech ideas to BTRN but the reason I like this company is their drug/methods/techniques for reprograming the immune system to prevent human to human organ rejection. MOGN and BTRN are my favorites (I own both). These and the other biotech stocks should get a real push during the fall research meetings. Last weeks volume and price movement for BTRN shows the value of research reports/meetings. I am sure Ben Graham is rolling over in his grave but patents are a valuable and undervalued asset.